Smart Publications

Clarifying the Complex World of Nutrition Science

  • Email this article
  • Print this article
  • A
  • A
  • A

Nattokinase: Powerful Enzyme Prevents Heart Attack and Stroke

Nattokinase: Powerful Enzyme Prevents Heart Attack and Stroke

Restores blood circulation

This is one of the most dramatic, documented stories about the effects of Nattokinase. A 58-year-old man had a blood clot in the retina of his right eye that caused fluid build up and bleeding. He started losing his vision in that eye and was admitted to a university hospital, where researchers prescribed a 3-ounce dose of natto to be taken before bed every night, in order to get the benefit of Nattokinase.

The man's bleeding completely stopped by the tenth day, and by the 20th day, his vision returned and he was released from the hospital. He continued to eat natto twice a week. When he had a retinal angiogram two months later, it showed that the blood clot was completely gone.12

Is Nattokinase for everyone?

This soy extract is considered extremely useful for those wanting a safe, drugless, non-aspirin alternative for healthy blood flow. Nattokinase is also a safe alternative for those who are off their feet because of illness, injury (including paralysis), or surgery.

Excellent for periods of inactivity

In the past few years, medical professionals began alerting the public about the increasing evidence that long flights and car trips put people at risk for deep vein thrombosis (DVT)—a blood clot that develops in a deep vein, usually in the leg. DVT is more common in women than in men, and in those over 40 years of age.

Deep vein thrombosis

DVT—blood clots inside veins found deep in extremities or body cavities—is a common disorder. A venous thrombus is a clump of blood cells, platelets, and fibrin (clot) which attaches to the inside walls of veins, can grow in size, and break off to travel downstream from the clot. If the clot stays localized, it can cause swelling and vein irritation. If part of it breaks off, it can cause blockage downstream, or become an embolus and result in a pulmonary embolus. In some instances, deep vein thrombosis may also contribute to other serious medical problems such as heart attack and stroke.

How safe is Nattokinase?

It is very safe when used according to the recommended dosage. People with ulcers, recent or pending surgery, or recent major trauma should not take Nattokinase. Anyone who has ever had neurosurgery or ischemic stroke in the previous six months should not take Nattokinase, as well as those who have had intracranial bleeding. Generally, people with bleeding disorders, or taking anti-clotting medication, should use this product only under the close supervision of a medical doctor.

Researchers have found that Nattokinase is four times more potent than plasmin, and works even more effectively than warfarin drugs because it continues to work for long periods of time, and it doesn't produce any side effects.

Conclusion

The traditional Japanese food Natto has been used safely for more than 1,000 years. The safety record of its potent fibrinolytic enzyme, Nattokinase, is based upon the long-term traditional use of the food and recent scientific studies.

Nattokinase has many benefits including its prolonged effects, cost effectiveness, and its ability to be used preventatively. It is a naturally occurring, food-based dietary supplement that has demonstrated stability in the gastrointestinal tract, as well as to changes in pH and temperature. It is definitely a nutritional supplement to consider adding to a cardiovascular health maintenance plan. 

Page 3 of 3 pages  < 1 2 3

Editor's Note:

The natural health solutions described in this article are available through many on-line retailers including those listed below. By clicking these links you help support the important alternative health research we provide.

Visit www.amazon.com – a great way to find competitive deals on supplements offered by many different manufacturers.

Visit www.hfn-usa.com – when commitment to quality and freshness is important, this factory direct solution is preferred by many of our readers.

This article is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a physician before embarking on a dietary supplement program.

References

  1. Soy intake shown to reduce mortality rate from cancer and CVD. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol. 2000 Oct;29(5):832-6. 

  2. Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S. Biochem Biophys Res Commun 1993 Dec 30;197(3):1340-7 Biotechnology Research Laboratories, JCR Pharmaceuticals Co., Ltd., Kobe, Japan. 

  3. Clinical trials.gov. Epidemiology of Coronary Heart Disease in Men Aged 40 and Over. August 2004. National Institutes of Health. Sept. 13, 2004. 

  4. Suzuki Y, Kondo K, Ichise H, Tsukamoto Y, Urano T, Umemura K. Dietary supplementation with fermented soybeans suppresses intimal thickening. Nutrition. 2003 Mar;19(3):261-4. 

  5. Prevent Heart Attack and Stroke with Potent Enzyme that Dissolves Deadly Blood Clots in Hours. Health Sciences Institute, March 2002. 

  6. Hager, K. et al. Fibrinogen and Aging. Aging (Milano) 1994, 6:133-38.

  7. Heinrich, J. et al. Fibrinogen and factor VII in the prediction of coronary risk. Arterioscler Thromb 1994, 14:54-59. 

  8. Sumi H. Interview With Doctor of Medicine Hiroyuki Sumi. Japan Bio Science Laboratory Co. Ltd. 

  9. Sumi, H. et al. "Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase." Acta haematol 1990, 84: 139-43.

  10. Suzuki Y, Kondo K, Matsumoto Y, Zhao BQ, Otsuguro K, Maeda T, Tsukamoto Y, Urano T, Umemura K. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sci. 2003 Jul 25;73(10):1289-98.

  11.  Maruyama M, Sumi H. Effect of Natto Diet on Blood Pressure.JTTAS, 1995.

  12. Nishimura, K. et al. Natto diet was apparently effective in a case of incipient central retinal vein occlusion. Japan Rev Clin Ophthalmol1994, 88:1381-85.

Articles of Interest from Smart Publications Health & Wellness Update